Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 29, 2022 - Issue 2
Submit an article Journal homepage
163
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

AH amyloid neuropathy: a novel clinical phenotype confirmed by histopathology and mass spectrometry

Nobuhiko Ohashia Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, JapanView further author information
,
Nagaaki Katohb Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto390-8621, JapanCorrespondence[email protected]
View further author information
,
Kazuki Kasugaa Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, JapanView further author information
,
Tsuneaki Yoshinagaa Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, JapanView further author information
,
Fuyuki Kametanic Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, JapanView further author information
,
Masahide Yazakid Clinical Laboratory Sciences Division, Shinshu University Graduate of School of Medicine, Matsumoto, Japan;e Institute for Biomedical Sciences, Shinshu University, Matsumoto, JapanView further author information
&
Yoshiki Sekijimaa Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan;e Institute for Biomedical Sciences, Shinshu University, Matsumoto, JapanView further author information
 show all
Pages 141-142 | Received 23 Dec 2021, Accepted 02 Mar 2022, Published online: 14 Mar 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"AH amyloid neuropathy: a novel clinical phenotype confirmed by histopathology and mass spectrometry." Amyloid, 29(2), pp. 141–142

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was supported by a grant from the Amyloidosis Research Committee, the Ministry of Health, Labour and Welfare, Japan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.